{"id":68897,"date":"2026-03-02T18:06:52","date_gmt":"2026-03-02T18:06:52","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68897"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"ipamorelin","status":"publish","type":"product","link":"https:\/\/medsbase.com\/fr\/product\/ipamorelin\/","title":{"rendered":"Ipamorelin"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">R\u00e9ponse rapide \u2014 Qu'est-ce que l'Ipamorelin ?<\/h3>\n<p style=\"margin: 0;\"><strong>Ipamorelin<\/strong> est un pentapeptide synth\u00e9tique s\u00e9cr\u00e9tagogue d'hormone de croissance qui se lie au r\u00e9cepteur de la ghr\u00e9line (GHS-R1a) pour d\u00e9clencher une lib\u00e9ration pulsatile de GH <strong>sans<\/strong> raising cortisol or prolactin \u2014 a selectivity that distinguishes it from older GHRPs. in studies it is frequently stacked with CJC-1295 to amplify GH pulse amplitude. Supplied in 2\u00a0mg to 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Ce que vous obtenez avec MedsBase :<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/fr\/reviews\/\">avis clients<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Chaque commande est couverte par notre <a href=\"https:\/\/medsbase.com\/fr\/medsbase-re-shipment-assurance-policy\/\"><strong>Politique de R\u00e9exp\u00e9ditions Garanties<\/strong><\/a> \u2014 si votre colis n'arrive pas dans les 20 jours ouvrables, nous le r\u00e9exp\u00e9dions.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Sp\u00e9cification<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">D\u00e9tail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Num\u00e9ro CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">170851-70-4<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formule mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>38<\/sub>H<sub>49<\/sub>N<sub>9<\/sub>O<sub>5<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Masse mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">711.86 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>S\u00e9quence<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Aib-His-D-2-Nal-D-Phe-Lys-NH<sub>2<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forme<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Poudre lyophilis\u00e9e (ou tel que fourni)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Puret\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599 % (v\u00e9rifi\u00e9 par HPLC, COA sur demande)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Stockage<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilis\u00e9 : 2\u20138 \u00b0C (r\u00e9frig\u00e9rateur) pour le stock de travail ; \u221220 \u00b0C pour le stockage \u00e0 long terme des flacons non ouverts. Reconstitu\u00e9 : 2\u20138 \u00b0C, \u00e0 utiliser dans ~30 jours. Prot\u00e9ger de la lumi\u00e8re. Ne pas congeler-d\u00e9congeler la solution reconstitu\u00e9e.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilit\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Eau bact\u00e9riostatique (recommand\u00e9e) ou eau st\u00e9rile pour des fen\u00eatres d'utilisation plus courtes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Qu'est-ce que l'Ipamorelin ?<\/h2>\n<p><strong>Ipamorelin<\/strong> est un pentapeptide synth\u00e9tique appartenant \u00e0 la famille des peptides lib\u00e9rateurs d'hormone de croissance (GHRP). D\u00e9velopp\u00e9 par Novo Nordisk dans les ann\u00e9es 1990 et caract\u00e9ris\u00e9 pour la premi\u00e8re fois par Raun et al. (Eur J Endocrinol, 1998), il est class\u00e9 comme un <strong>s\u00e9cr\u00e9tagogue d'hormone de croissance<\/strong> \u2014 a compound that triggers endogenous GH release by activating the ghrelin receptor (GHS-R1a) on pituitary somatotropes. Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH<sub>2<\/sub>. Masse mol\u00e9culaire d'environ 711,9 Da. Contrairement aux GHRP pr\u00e9c\u00e9dents (GHRP-2, GHRP-6, hexar\u00e9line), l'ipamor\u00e9line se distingue par son <strong>\u2014 elle lib\u00e8re l'hormone de croissance sans augmenter significativement le cortisol, la prolactine ou l'ACTH. Cette s\u00e9lectivit\u00e9 explique pourquoi l'ipamor\u00e9line est devenue le GHRP le plus \u00e9tudi\u00e9 du 21e si\u00e8cle. Elle est fournie sous forme de poudre lyophilis\u00e9e de haute puret\u00e9 \u00e0 reconstituer avec de l'eau bact\u00e9riostatique. L'ipamor\u00e9line est<\/strong> \u2014 it releases GH without meaningfully raising cortisol, prolactin, or ACTH. This selectivity is why ipamorelin has become the most-studied GHRP of the 21st century. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. For mechanism, published studies, and stacking protocols, see our <a href=\"https:\/\/medsbase.com\/fr\/ipamorelin-cjc-1295-stack-guide\/\">Ipamorelin &amp; CJC-1295 guide<\/a>. <\/p>\n<h2>M\u00e9canisme d'action \u2014 Agonisme s\u00e9lectif du r\u00e9cepteur de la ghr\u00e9line<\/h2>\n<p>r\u00e9cepteur de type 1a des s\u00e9cr\u00e9tagogues de l'hormone de croissance (GHS-R1a) <strong>r\u00e9cepteur de type 1a des s\u00e9cr\u00e9tagogues de l'hormone de croissance (GHS-R1a)<\/strong>, le r\u00e9cepteur endog\u00e8ne de la ghr\u00e9line. Ce r\u00e9cepteur est exprim\u00e9 sur les somatotropes hypophysaires et dans le noyau arqu\u00e9 de l'hypothalamus, et son activation d\u00e9clenche une lib\u00e9ration pulsatile d'hormone de croissance \u00e0 partir des granules de stockage hypophysaires. <\/p>\n<ul>\n<li><strong>Lib\u00e9ration pulsatile de GH<\/strong> \u2014 contrairement \u00e0 l'administration continue de GH recombinante, l'ipamorelin produit un <em>profil pulsatile<\/em> de GH qui imite plus \u00e9troitement les pics nocturnes endog\u00e8nes de GH. Cette pulsatilit\u00e9 est importante sur le plan m\u00e9canistique car la signalisation IGF-1 r\u00e9pond mieux \u00e0 une exposition puls\u00e9e qu'continue \u00e0 la GH.<\/li>\n<li><strong>S\u00e9lectivit\u00e9 hormonale propre<\/strong> \u2014 the defining feature of ipamorelin. Older GHRPs (GHRP-2, GHRP-6, hexarelin) also raise cortisol and prolactin, producing off-target effects that complicate studies interpretation. Ipamorelin does not, making it the preferred GHRP for studies where those confounders matter.<\/li>\n<li><strong>Compl\u00e9mentarit\u00e9 avec la GHRH<\/strong> \u2014 l'ipamorelin agit via la voie du r\u00e9cepteur de la ghr\u00e9line ; les analogues de la GHRH tels que <a href=\"https:\/\/medsbase.com\/fr\/cjc-1295-with-dac\/\">CJC-1295<\/a> act via a parallel GHRH-receptor pathway. Co-administration produces synergistic GH pulse amplification greater than either peptide alone \u2014 the basis of the classic &#8220;ipamorelin + CJC-1295&#8221; stack.<\/li>\n<\/ul>\n<p>Because ipamorelin works through the body&#8217;s own pituitary GH supply, it is subject to normal negative-feedback regulation by somatostatin and IGF-1. This auto-regulation is a studies-relevant safety feature distinguishing secretagogues from exogenous recombinant GH. <\/p>\n<h2>Published Evidence<\/h2>\n<p>Ipamorelin is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>GH pulse studies<\/strong> \u2014 cin\u00e9tique de lib\u00e9ration pulsatile de l'hormone de croissance et r\u00e9ponse de l'IGF-1 dans des mod\u00e8les rongeurs (Raun et al., Eur J Endocrinol 1998)<\/li>\n<li><strong>R\u00e9cup\u00e9ration musculaire squelettique<\/strong> \u2014 r\u00e9cup\u00e9ration post-l\u00e9sion et post-exercice, souvent associ\u00e9e \u00e0 <a href=\"https:\/\/medsbase.com\/fr\/bpc-157\/\">BPC-157<\/a> et <a href=\"https:\/\/medsbase.com\/fr\/tb-500\/\">TB-500<\/a><\/li>\n<li><strong>Body composition studies<\/strong> \u2014 lean-mass preservation and fat-mass studies, often in caloric-deficit or disuse-atrophy models<\/li>\n<li><strong>Sleep studies<\/strong> \u2014 slow-wave sleep and nocturnal GH-surge studies; pre-sleep dosing is the typical studies timing<\/li>\n<li><strong>Bone density studies<\/strong> \u2014 activit\u00e9 des ost\u00e9oblastes et densit\u00e9 min\u00e9rale osseuse via la modulation de l'axe GH\/IGF-1<\/li>\n<li><strong>CJC-1295 stacking studies<\/strong> \u2014 protocoles d'amplification synergique de GH avec des analogues de GHRH (voir le <a href=\"https:\/\/medsbase.com\/fr\/ipamorelin-cjc-1295-stack-guide\/\">Guide d'empilement Ipamorelin + CJC-1295<\/a>)<\/li>\n<\/ul>\n<p>Pour un contexte plus large sur le paysage des peptides de l'axe GH, voir <a href=\"https:\/\/medsbase.com\/fr\/peptides\/\">the peptides catalog<\/a>. <\/p>\n<h2>Forces et concentrations disponibles<\/h2>\n<p>MedsBase propose de l'ipamorelin dans les tailles de flacons lyophilis\u00e9s suivantes. Chaque vari\u00e9t\u00e9 est exp\u00e9di\u00e9e en formats de 10, 20 ou 30 flacons :<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Concentration du flacon<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Cas d'utilisation typique<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tailles de conditionnement<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>2 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, pilot dosing<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, most commonly ordered<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Extended studies, lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). A 5\u00a0mg vial at 2.5\u00a0mg\/mL dilution delivers approximately 16 administrations of 300\u00a0mcg, matching common protocols. <\/p>\n<h2>Comparaison \u2014 Ipamorelin vs CJC-1295<\/h2>\n<p>Ipamorelin et <a href=\"https:\/\/medsbase.com\/fr\/cjc-1295-with-dac\/\">CJC-1295 avec DAC<\/a> sont les deux peptides de l'axe GH les plus \u00e9tudi\u00e9s. Ils sont presque universellement co-administr\u00e9s plut\u00f4t que substitu\u00e9s, car ils agissent sur <em>parall\u00e8les<\/em> des syst\u00e8mes de r\u00e9cepteurs qui produisent une synergie ensemble :<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e8re<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Ipamorelin<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">CJC-1295 avec DAC<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Classe de peptide<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GHRP (peptide lib\u00e9rateur d'hormone de croissance)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Analogue de GHRH (hormone de lib\u00e9ration de l'hormone de croissance)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>R\u00e9cepteur<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GHS-R1a (r\u00e9cepteur de la ghr\u00e9line)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">R\u00e9cepteur GHRH sur les somatotropes<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Effet sur la GH<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Lib\u00e9ration pulsatile en rafale<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u00c9l\u00e9vation soutenue de la ligne de base<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Demi-vie<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~2 heures<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~7 jours (li\u00e9 \u00e0 l'albumine)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Posologie<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">200\u2013300\u00a0mcg, 2\u20133 fois par jour<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u20132\u00a0mg par semaine<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Empilement<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Association canonique avec le CJC-1295<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Association canonique avec l'ipamor\u00e9line<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>La logique compl\u00e8te du stacking, le timing des doses et l'analyse des m\u00e9canismes de synergie se trouvent dans notre <a href=\"https:\/\/medsbase.com\/fr\/ipamorelin-cjc-1295-stack-guide\/\">Ipamorelin and CJC-1295 stack guide<\/a>. <\/p>\n<h2>Stockage et reconstitution<\/h2>\n<p><strong>Avant la reconstitution :<\/strong> conserver les flacons lyophilis\u00e9s au r\u00e9frig\u00e9rateur entre 2 et 8 \u00b0C dans leur emballage d'origine, stables jusqu'\u00e0 36 mois. \u00c9viter les cycles de cong\u00e9lation-d\u00e9cong\u00e9lation de la poudre. <strong>Proc\u00e9dure de reconstitution :<\/strong> injecter de l'eau bact\u00e9riostatique le long de la paroi du flacon de peptide selon le tableau ci-dessus. Agiter doucement \u2014 ne pas <strong>re\u00e7oit pas<\/strong> agiter \u2014 et laisser 5 \u00e0 10 minutes pour une dissolution compl\u00e8te. Une solution correctement reconstitu\u00e9e doit \u00eatre claire et incolore. <strong>Apr\u00e8s reconstitution :<\/strong> conserver au r\u00e9frig\u00e9rateur entre 2 et 8 \u00b0C et utiliser dans les 30 jours. Ne pas congeler la solution reconstitu\u00e9e \u2014 les cycles de cong\u00e9lation-d\u00e9cong\u00e9lation alt\u00e8rent l'int\u00e9grit\u00e9 du peptide. <\/p>\n<h2 id=\"faqs\">Questions fr\u00e9quemment pos\u00e9es<\/h2>\n<h3>What is ipamorelin used for in studies?<\/h3>\n<p>Ipamorelin is used in studies investigating pulsatile growth hormone release, IGF-1 axis signaling, skeletal muscle recovery, body composition, sleep studies, bone density, and GH-axis stacking with GHRH analogs. It is <strong>re\u00e7oit pas<\/strong> FDA-approved and is sold here strictly for clinical studies use only. <\/p>\n<h3>What is the typical ipamorelin dose?<\/h3>\n<p>Published preclinical protocols typically use 200\u2013300\u00a0mcg per administration, 2\u20133 times daily, often with one dose timed pre-sleep to align with nocturnal GH-surge studies. A 5\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 2.5\u00a0mg\/mL \u2014 12 ticks on a U-100 syringe delivers 300\u00a0mcg. <\/p>\n<h3>En quoi l'ipamor\u00e9line diff\u00e8re-t-elle de la CJC-1295 ?<\/h3>\n<p>L'ipamor\u00e9line est un peptide lib\u00e9rateur d'hormone de croissance (GHRP) qui se lie au r\u00e9cepteur de la ghr\u00e9line pour une lib\u00e9ration pulsatile de GH. La CJC-1295 est un analogue de l'hormone lib\u00e9ratrice d'hormone de croissance (GHRH) qui se lie \u00e0 un r\u00e9cepteur diff\u00e9rent sur les m\u00eames cellules hypophysaires pour une \u00e9l\u00e9vation soutenue de la GH. Les deux sont g\u00e9n\u00e9ralement associ\u00e9s car leurs m\u00e9canismes sont additifs\/synergiques. <\/p>\n<h3>L'ipamor\u00e9line est-elle approuv\u00e9e par la FDA ?<\/h3>\n<p>No. Ipamorelin is not approved by the FDA, EMA, MHRA, or any other regulator for human therapeutic use. It has been studied in early-phase human clinical trials but never advanced to approval. All ipamorelin sold by specialist suppliers is for clinical investigation only. <\/p>\n<h3>Pourquoi l'ipamor\u00e9line est-elle pr\u00e9f\u00e9r\u00e9e aux anciens GHRP comme le GHRP-6 ?<\/h3>\n<p>Ipamorelin&#8217;s defining feature is clean hormonal selectivity \u2014 it releases GH without raising cortisol, prolactin, or ACTH. Older GHRPs (GHRP-2, GHRP-6, hexarelin) raise all three, producing off-target effects that complicate studies interpretation and produce unwanted side effects. This selectivity has made ipamorelin the most-studied GHRP of the past two decades. <\/p>\n<h3>Comment l'ipamor\u00e9line doit-elle \u00eatre stock\u00e9e ?<\/h3>\n<p>Flacons lyophilis\u00e9s : r\u00e9frig\u00e9r\u00e9s \u00e0 2\u20138 \u00b0C dans leur emballage d'origine, stables jusqu'\u00e0 36 mois. Solution reconstitu\u00e9e : r\u00e9frig\u00e9r\u00e9e \u00e0 2\u20138 \u00b0C, \u00e0 utiliser dans les 30 jours. Ne pas congeler la solution reconstitu\u00e9e \u2014 les cycles de gel-d\u00e9gradation alt\u00e8rent le peptide. <\/p>\n<h3>Comment reconstituer l'ipamor\u00e9line ?<\/h3>\n<p>Suivez le tableau de reconstitution ci-dessus. Ajoutez de l'eau bact\u00e9riostatique le long de la paroi lat\u00e9rale du flacon, agitez doucement et laissez reposer 5 \u00e0 10 minutes pour une dissolution compl\u00e8te. Ne <strong>re\u00e7oit pas<\/strong> secouez pas le flacon. <\/p>\n<h3>Can ipamorelin and CJC-1295 be stacked in studies?<\/h3>\n<p>Yes. The ipamorelin + CJC-1295 combination is the canonical GH-axis stack. The two peptides act on parallel receptor systems (ghrelin vs GHRH receptor) and their effects on GH release are synergistic \u2014 combined use produces larger GH pulses than either alone. See our <a href=\"https:\/\/medsbase.com\/fr\/ipamorelin-cjc-1295-stack-guide\/\">guide d'association<\/a>. <\/p>\n<h3>Quelles sont les dosages disponibles chez MedsBase ?<\/h3>\n<p>MedsBase propose de l'ipamor\u00e9line en flacons lyophilis\u00e9s de 2 mg, 5 mg et 10 mg. Chaque concentration est disponible en packs de 10, 20 ou 30 flacons. Tous les flacons sont fournis avec une puret\u00e9 HPLC de 99 %+ et un certificat d'analyse sur demande. <\/p>\n<h3>Does ipamorelin cause side reported effects?<\/h3>\n<p>Ipamorelin has been reported with a clean safety profile at typical doses. Its selective receptor binding avoids the cortisol and prolactin elevation seen with older GHRPs. Long-term human safety data are not available because human trials were not completed. <\/p>\n<h3>Why is pre-sleep timing used in ipamorelin studies?<\/h3>\n<p>Endogenous growth-hormone release is naturally pulsatile and strongest during slow-wave sleep. Study protocols typically time one ipamorelin dose 30\u201360 minutes before sleep to amplify the natural nocturnal GH surge rather than compete with daytime somatostatin tone. <\/p>\n<h3>Quelle est la demi-vie de l'Ipamorelin ?<\/h3>\n<p>Ipamorelin has a short plasma half-life of approximately 2 hours in preclinical studies, consistent with the broader GHRP peptide class. This rapid clearance underpins the pulsatile, multiple-daily dosing schedules most commonly used in ipamorelin protocols. <\/p>\n<h3>How does Ipamorelin compare to GHRP-6 in studies?<\/h3>\n<p>Ipamorelin is highly selective for the GHSR-1a receptor and does not significantly elevate cortisol or prolactin in preclinical studies \u2014 a key distinction from GHRP-6, which activates ghrelin receptors more broadly and is associated with transient cortisol and prolactin increases. This selectivity is a primary reason ipamorelin is frequently preferred in published GH-secretagogue studies. <\/p>\n<h3>Puis-je commander de l'ipamorelin pour une livraison internationale ?<\/h3>\n<p>Oui. MedsBase exp\u00e9die l'ipamorelin dans le monde entier depuis notre r\u00e9seau d'exp\u00e9dition d\u00e9di\u00e9 aux peptides. Les commandes de peptides uniquement sont \u00e9ligibles \u00e0 notre service d'exp\u00e9dition de peptides autonome. Les commandes sont exp\u00e9di\u00e9es dans un emballage \u00e0 temp\u00e9rature contr\u00f4l\u00e9e avec un suivi complet. <\/p>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-peptide-healing-stack\">Si votre protocole de r\u00e9cup\u00e9ration associe la stimulation des pulsations de GH par l'ipamorelin \u00e0 des peptides de r\u00e9paration tissulaire directe pour les tendons ou les ligaments, notre <a href=\"\/fr\/peptide-healing-stack\/\">Cure de peptides cicatrisants (BPC-157 5 mg + TB-500 5 mg)<\/a> couvre le c\u00f4t\u00e9 angiogen\u00e8se + r\u00e9paration cytosquelettique du r\u00e9gime avec de l'eau bact\u00e9riostatique incluse pour la reconstitution.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/fr\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/fr\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/fr\/cjc-1295-with-dac\/\"><strong>CJC-1295 avec DAC<\/strong><\/a> \u2014 Analogue de GHRH avec demi-vie prolong\u00e9e<\/li>\n<li><a href=\"\/fr\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<li><a href=\"\/fr\/igf-1-lr3\/\"><strong>IGF-1 LR3<\/strong><\/a> \u2014 Long-R3 IGF-1 analog \u2014 anabolic \/ regenerative support<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Pour en savoir plus<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Lisez notre guide complet bas\u00e9 sur des preuves : <a href=\"https:\/\/medsbase.com\/fr\/ipamorelin-cjc-1295-stack-guide\/\"><strong>Ipamorelin &amp; CJC-1295 \u2014 m\u00e9canisme, combinaison et protocoles<\/strong><\/a>. Couvre le m\u00e9canisme d'action, la pharmacologie des r\u00e9cepteurs de la ghr\u00e9line vs GHRH, les protocoles de combinaison publi\u00e9s, la reconstitution, le timing des doses et les notes de s\u00e9curit\u00e9.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Favorise la masse musculaire maigre<br \/>\n\u2705 Am\u00e9liore les voies de r\u00e9cup\u00e9ration<br \/>\n\u2705 Favorise l'\u00e9quilibre m\u00e9tabolique<br \/>\n\u2705 Am\u00e9liore les cycles de sommeil<br \/>\n\u2705 Stimule la r\u00e9paration tissulaire<\/p>\n<p><strong>Ipamorelin<\/strong> contient un compos\u00e9 peptidique synth\u00e9tique.<\/p>","protected":false},"featured_media":70961,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5457],"class_list":["post-68897","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-ipamorelin","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product\/68897","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/comments?post=68897"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media\/70961"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media?parent=68897"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_brand?post=68897"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_cat?post=68897"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_tag?post=68897"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}